Login to Your Account



New liver cancer cell line to facilitate vaccine, antiviral development

By John Fox
Staff Writer

Wednesday, March 19, 2014

HONG KONG – Chinese scientists have developed a human liver cancer cell line that replicates the entire life cycle of both the hepatitis B and hepatitis C viruses, providing a powerful tool with which to study the natural history of these pathogens and help in developing new antivirals and vaccines.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription